The New York Times editorial board does not relish alienating big business. So plenty of heads turned last week when the Gray Lady threw down a gauntlet in a full-column editorial titled “Save America’s Patent System.” The Times editorialists excoriated Big Pharma for abusing the American intellectual-property system to jack up prices on drugs and More

The post How Drug Companies Use Intellectual-Property Laws to Price Gouge the Public appeared first on CounterPunch.org.

This post was originally published on CounterPunch.org.